Retinoblastoma staging: Difference between revisions
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
{| | {| | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Stage | ||
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | | colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Description | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Stage 0 | ||
| colspan="6" style="background: #F5F5F5; padding: 5px;" | | | colspan="6" style="background: #F5F5F5; padding: 5px;" |Eye enucleated and no dissemination of the disease | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Stage I | ||
| colspan="6" style="background: #F5F5F5; padding: 5px;" | | | colspan="6" style="background: #F5F5F5; padding: 5px;" |Eye enucleated, completely resected histologically | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Stage II | ||
| colspan="6" style="background: #F5F5F5; padding: 5px;" | | | colspan="6" style="background: #F5F5F5; padding: 5px;" |Eye enucleated, microscopic residual tumor | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Stage III | ||
| colspan="3" style="background: #F5F5F5; padding: 5px;" | | | colspan="3" style="background: #F5F5F5; padding: 5px;" |Regional extension | ||
| colspan="3" style="background: #F5F5F5; padding: 5px;" | | | colspan="3" style="background: #F5F5F5; padding: 5px;" |a.Overt orbital disease | ||
b.Preauricular or cervical lymph node extension | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Stage IV | ||
| colspan="3" style="background: #F5F5F5; padding: 5px;" | | | colspan="3" style="background: #F5F5F5; padding: 5px;" |Metastatic disease | ||
| colspan="3" style="background: #F5F5F5; padding: 5px;" | | | colspan="3" style="background: #F5F5F5; padding: 5px;" |a.Hematogenous metastasis (without CNS involvement) | ||
—Single lesion | |||
—Multiple lesions | |||
b.CNS extension (with or without any other site of regional or metastatic disease) | |||
—Prechiasmatic lesion | |||
—CNS mass | |||
—Leptomeningeal and CSF disease | |||
|} | |} | ||
Revision as of 15:44, 25 April 2019
Retinoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Retinoblastoma staging On the Web |
American Roentgen Ray Society Images of Retinoblastoma staging |
Risk calculators and risk factors for Retinoblastoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
According to the International classification of retinoblastoma, there are five stages of retinoblastoma based on the tumor size, location, local spread, neovascular glaucoma, intravascular hemorrhage, and orbital cellulitis.
Staging
- There is two known staging system for retinoblastoma:
- American Joint Committee on Cancer (AJCC) staging system
- International Retinoblastoma Staging System
- This staging system is used in the clinical setting greater than the AJCC staging system.
Stage | Description | |||||
---|---|---|---|---|---|---|
Stage 0 | Eye enucleated and no dissemination of the disease | |||||
Stage I | Eye enucleated, completely resected histologically | |||||
Stage II | Eye enucleated, microscopic residual tumor | |||||
Stage III | Regional extension | a.Overt orbital disease
b.Preauricular or cervical lymph node extension | ||||
Stage IV | Metastatic disease | a.Hematogenous metastasis (without CNS involvement)
—Single lesion —Multiple lesions b.CNS extension (with or without any other site of regional or metastatic disease) —Prechiasmatic lesion —CNS mass —Leptomeningeal and CSF disease |